Ads

You May Also Like

Orphazyme reports positive results from full data set of Phase II/III arimoclomol trial in Niemann-Pick disease Type C (NPC)

Orphazyme A/SCompany announcement                                                                                                                   No. 01/2019                                                                                             ...

Biocartis Group NV: Invitation to annual shareholders meeting

   PRESS RELEASE: REGULATED INFORMATION 11 April 2017, 07:00 CEST                ...